Residual Humoral Immunity Sustained Over Decades in a Cohort of Vaccinia-Vaccinated Individuals
- PMID: 36200239
- DOI: 10.1093/infdis/jiac409
Residual Humoral Immunity Sustained Over Decades in a Cohort of Vaccinia-Vaccinated Individuals
Abstract
Serological testing of Singaporeans who received childhood smallpox vaccination found anti-vaccinia IgG binding and neutralizing activity indicating long-term humoral immunity. There was correlation between IgG and neutralizing titers indicating IgG could be used as a surrogate marker for humoral immunity. In 2019, Singapore experienced a case of imported monkeypox. As with smallpox, disease can be prevented through vaccination, which was mandatory for Singaporean infants until 1981. However, the degree of residual immunity in older vaccinated Singaporeans remains unknown. Sera from individuals born 1946-1984 were therefore tested and those born prior to 1981 were found to have higher anti-vaccinia IgG and neutralizing activity titers. This suggests that protective humoral immunity remains, which could reduce disease severity in an orthopoxvirus outbreak. Correlation between IgG and neutralizing titers was observed indicating that serology could be used as a surrogate marker for immunity.
Keywords: monkeypox; smallpox; vaccinia.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Similar articles
-
Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.PLoS One. 2017 Jan 3;12(1):e0169247. doi: 10.1371/journal.pone.0169247. eCollection 2017. PLoS One. 2017. PMID: 28046039 Free PMC article.
-
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.Cell Host Microbe. 2023 Jun 14;31(6):937-948.e4. doi: 10.1016/j.chom.2023.05.001. Epub 2023 May 5. Cell Host Microbe. 2023. PMID: 37196656 Free PMC article.
-
Serological Immunity to Smallpox in New South Wales, Australia.Viruses. 2020 May 18;12(5):554. doi: 10.3390/v12050554. Viruses. 2020. PMID: 32443405 Free PMC article.
-
Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine.Vaccine. 2017 Dec 19;35(52):7222-7230. doi: 10.1016/j.vaccine.2017.11.003. Epub 2017 Nov 11. Vaccine. 2017. PMID: 29137821 Review.
-
Smallpox vaccines: targets of protective immunity.Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x. Immunol Rev. 2011. PMID: 21198662 Free PMC article. Review.
Cited by
-
Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response.Vaccines (Basel). 2024 Aug 26;12(9):964. doi: 10.3390/vaccines12090964. Vaccines (Basel). 2024. PMID: 39339995 Free PMC article.
-
Smallpox vaccination campaigns resulted in age-associated population cross-immunity against monkeypox virus.J Gen Virol. 2024 Jun;105(6):001999. doi: 10.1099/jgv.0.001999. J Gen Virol. 2024. PMID: 38861287 Free PMC article.
-
Non-replicating vaccinia virus NTV as an effective next-generation smallpox and monkeypox vaccine: evidence from mouse and rhesus monkey models.Emerg Microbes Infect. 2023 Dec;12(2):2278900. doi: 10.1080/22221751.2023.2278900. Epub 2023 Dec 6. Emerg Microbes Infect. 2023. PMID: 37916732 Free PMC article. No abstract available.
-
Distinct evolutionary patterns of endemic and emerging parvoviruses, and the origin of a new pandemic virus.bioRxiv [Preprint]. 2025 Jul 18:2025.07.14.664739. doi: 10.1101/2025.07.14.664739. bioRxiv. 2025. PMID: 40791396 Free PMC article. Preprint.
-
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination.Vaccines (Basel). 2023 Sep 28;11(10):1541. doi: 10.3390/vaccines11101541. Vaccines (Basel). 2023. PMID: 37896943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials